Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 219

1.

Regional Trends in Mortality from Alcohol-Induced Causes in the United States, 2000-2017.

Cholankeril G, Dennis BB, Kim D, Ahmed A.

J Gen Intern Med. 2019 Dec 2. doi: 10.1007/s11606-019-05442-4. [Epub ahead of print] No abstract available.

PMID:
31792862
2.

Association Between a Polymorphism in MBOAT7 and Chronic Kidney Disease in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease.

Koo BK, An JN, Joo SK, Kim D, Lee S, Bae JM, Park JH, Kim JH, Chang MS, Kim W.

Clin Gastroenterol Hepatol. 2019 Sep 20. pii: S1542-3565(19)31022-5. doi: 10.1016/j.cgh.2019.09.017. [Epub ahead of print]

PMID:
31546054
3.

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis.

Kim D, Kim W, Joo SK, Han J, Kim JH, Harrison SA, Younossi ZM, Ahmed A.

J Gastroenterol. 2019 Sep 18. doi: 10.1007/s00535-019-01628-z. [Epub ahead of print]

PMID:
31535207
4.

Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease.

Adejumo AC, Kim D, Iqbal U, Yoo ER, Boursiquot BC, Cholankeril G, Wong RJ, Kwo PY, Ahmed A.

J Palliat Med. 2019 Aug 9. doi: 10.1089/jpm.2019.0100. [Epub ahead of print]

PMID:
31397615
5.

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.

Adejumo AC, Cholankeril G, Iqbal U, Yoo ER, Boursiquot BC, Concepcion WC, Kim D, Ahmed A.

Dig Dis Sci. 2019 Aug 1. doi: 10.1007/s10620-019-05759-4. [Epub ahead of print]

PMID:
31372912
6.

Depression is associated with non-alcoholic fatty liver disease among adults in the United States.

Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Harrison SA, Ahmed A.

Aliment Pharmacol Ther. 2019 Sep;50(5):590-598. doi: 10.1111/apt.15395. Epub 2019 Jul 22.

PMID:
31328300
7.

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary.

Dibba P, Li AA, Cholankeril G, Ali Khan M, Kim D, Ahmed A.

Nutr Metab Insights. 2019 May 13;12:1178638819847480. doi: 10.1177/1178638819847480. eCollection 2019.

8.

Association between advanced fibrosis in fatty liver disease and overall mortality based on body fat distribution.

Chung GE, Heo NJ, Kim D, Kwak MS, Yim JY, Kim JS, Ahmed A.

J Gastroenterol Hepatol. 2019 Jul 4. doi: 10.1111/jgh.14778. [Epub ahead of print]

PMID:
31272131
9.

Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.

Kim D, Adejumo AC, Yoo ER, Iqbal U, Li AA, Pham EA, Cholankeril G, Glenn JS, Ahmed A.

Gastroenterology. 2019 Oct;157(4):1055-1066.e11. doi: 10.1053/j.gastro.2019.06.026. Epub 2019 Jun 25.

PMID:
31251928
10.

Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association.

Li AA, Ahmed A, Kim D.

Hepatobiliary Surg Nutr. 2019 Jun;8(3):260-261. doi: 10.21037/hbsn.2018.12.10. No abstract available.

11.

Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017.

Kim D, Cholankeril G, Kim SH, Abbasi F, Knowles JW, Ahmed A.

Clin Gastroenterol Hepatol. 2019 Jun 17. pii: S1542-3565(19)30649-4. doi: 10.1016/j.cgh.2019.06.011. [Epub ahead of print]

PMID:
31220638
12.

Lysophosphatidic Acid Signaling in Diabetic Nephropathy.

Lee JH, Kim D, Oh YS, Jun HS.

Int J Mol Sci. 2019 Jun 11;20(11). pii: E2850. doi: 10.3390/ijms20112850. Review.

13.

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.

Li AA, Ahmed A, Kim D.

Gut Liver. 2019 Jun 17. doi: 10.5009/gnl19069. [Epub ahead of print]

14.

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.

Cholankeril G, Li AA, Dennis BB, Gadiparthi C, Kim D, Toll AE, Maliakkal BJ, Satapathy SK, Nair S, Ahmed A.

Sci Rep. 2019 Jun 5;9(1):8312. doi: 10.1038/s41598-019-44814-y.

15.

Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers.

Gadiparthi C, Yoo ER, Are VS, Charilaou P, Kim D, Cholankeril G, Pitchumoni C, Ahmed A.

Ann Hepatol. 2019 Sep - Oct;18(5):679-684. doi: 10.1016/j.aohep.2019.04.014. Epub 2019 May 21.

16.

Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm.

Cho Y, Lim SK, Joo SK, Jeong DH, Kim JH, Bae JM, Park JH, Chang MS, Lee DH, Jung YJ, Kim BG, Kim D, Lee KL, Kim W.

Liver Int. 2019 Sep;39(9):1722-1731. doi: 10.1111/liv.14163. Epub 2019 Jun 26.

PMID:
31162812
17.

Economic burden and healthcare utilization in nonalcoholic fatty liver disease.

Yoo ER, Ahmed A, Kim D.

Hepatobiliary Surg Nutr. 2019 Apr;8(2):181-183. doi: 10.21037/hbsn.2018.12.11. No abstract available.

18.

Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.

Wijarnpreecha K, Panjawatanan P, Aby E, Ahmed A, Kim D.

Maturitas. 2019 Jun;124:48-54. doi: 10.1016/j.maturitas.2019.03.016. Epub 2019 Mar 25. Review.

PMID:
31097179
19.

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.

Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A.

Liver Int. 2019 Sep;39(9):1661-1671. doi: 10.1111/liv.14135. Epub 2019 Jun 4.

PMID:
31081997
20.

Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017.

Kim D, Li AA, Cholankeril G, Kim SH, Ingelsson E, Knowles JW, Harrington RA, Ahmed A.

Diabetologia. 2019 Jul;62(7):1185-1194. doi: 10.1007/s00125-019-4870-9. Epub 2019 Apr 22.

PMID:
31011776

Supplemental Content

Loading ...
Support Center